Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Search

Search Results for cancer

GSK hopeful of a 'blockbuster' cancer drug after promising trial results
News

GSK hopeful of a 'blockbuster' cancer drug after promising trial results

Mo-Rez shrank or eliminated tumours in 62 percent patients with ovarian cancer, and in 67 percent of those with endometrial cancer

MHRA approves lung cancer drug Sevabertinib
News

MHRA approves lung cancer drug Sevabertinib

Sevabertinib blocks abnormal HER2 protein which drives the growth of cancer cells

£42 million prostate cancer screening trial begins
News

£42 million prostate cancer screening trial begins

The Transform trial launches in London, testing PSA blood tests, MRI scans, and genetic "spit tests" to find the most effective way to detect the disease early

AI Beats Doctors at Detecting Breast Cancer: Study
Technology & Digital Health

AI beats doctors at spotting breast cancer: Study

Breast Cancer is a common type of cancer found in the UK with a woman diagnosed every ten minutes

MHRA approves new pill to treat breast cancer
News

MHRA approves new pill to treat breast cancer

Inluriyo can be used to treat cancers that are locally advanced or has spread to other parts of the body and hasn’t responded to hormonal treatment

Ziihera Wins MHRA Nod for Biliary Cancer
Drug Safety & Medicine Alerts

Ziihera gains MHRA approval for treating biliary tract cancer

The approval was granted to Jazz Pharmaceuticals Research UK Limited

Boots awareness campaign for early detection of lung cancer
Respiratory & Lung Health

Boots launches awareness campaign for early detection of lung cancer

Lung cancer is the third most common type of cancer in the UK, with 49,000 people diagnosed with the disease each year

Pharmacy leaders welcome expanded role for community pharmacies in National Cancer Plan
News

Pharmacy leaders welcome expanded role for community pharmacies in National Cancer Plan

Community pharmacies will offer first-line tests to people who have symptoms that could indicate cancer